Call us today at (423) 989-8000

501 5th St., Bristol, TN 37620 |

UPM's New 475,000 square foot commercial facility
Key Features
  • Solid Oral Dosage Forms
  • Semi Solid Dosage Forms
  • Full Analytical Capabilities

UPM Recognized at CMO Awards
  • Winner of the 2015 Industry Choice Award for Mid-Sized & Emerging Pharma
  • Recognized in Innovation, Productivity, Quality, Regulatory, Reliability
  • 4th Consecutive Year of CMO Recognition

UPM Pharmaceuticals Recognized at CMO Awards
Key Features
  • Low cost - Smaller financial commitment
  • High quality "Proof-of-Concept" results
  • Target batch size 100 - 500 grams
  • Containment conditions available
  • Scale up to GMP batch sizes and equipment available at UPM.
BREVI-BATCH High Quality R&D Feasibility Processing
Korsch Bi / Tri-Layer Tableting
Key Features
  • State of the art multi-function platform designed for maximum efficiency and utilization
  • On-board PharmaControl system for precise tablet monitoring and control
  • Bi & Tri-layer Tableting
  • 70,000 tablets/hr
UPM Pharmaceuticals Low Solubility Solutions Capabilities
Low Solubility Solutions
Key Features
  • Full equipment train for processing of poorly soluble compounds such as, Hot Melt Extruder, Liquid-fill-hard gelatin encapsulator
  • Spray Dryer, particle size reduction mills and nano-homogenizers
  • Strategic scientific based customized plan Not locked into a proprietary technology of fixed pricing program
UPM Pharmaceuticals Low Solubility Solutions Capabilities
Key Features
  • Handling of potent and cytotoxic compounds
  • Humidity Controlled for moisture sensitive compounds
Key Features
  • Fette 52 I Bi-Layer Tablet Press for bilayer tablets
  • MG-Planeta for granule, mini-tablet and/or powder combinations
UPM Pharmaceuticals Combination Drugs Solutions
New Capabilities at UPM

Contract Development & Manufacturing Organization

At UPM Pharmaceuticals, scientific sophistication and experience come together with flexibility, responsiveness and innovation. UPM is a contract development & manufacturing organization (CMO) providing pharmaceutical drug development services, including formulation development, GMP clinical and commercial manufacturing, analytical methods development and stability testing.

UPM Featured in Contract Pharma Magazine

UPM Pharmaceuticals CEO James E. Gregory is a featured contributor in the October 2015 issue of Contract Pharma Magazine with an article about third-party providers and how they support all stages of drug development. Click here to read the article.


Our drug development services are characterized by a core commitment to meeting the client’s objectives with the highest quality, while maintaining the most efficient use of time and controlling costs. Our pharmaceutical development team applies its extensive experience as an award-winning CMO in developing creative solutions to your unique challenges. UPM takes enormous pride in supporting pharmaceutical companies at every step of the of the drug development process.

UPM Pharmaceuticals, Inc. provides the following pharmaceutical development services:

Throughout the project, our contract development and manufacturing organization will work to advance and optimize your product through scientific and customized approaches. UPM has highly trained staff, detailed scheduling processes and a broad array of research and manufacturing scale equipment to ensure your project is successfully completed with quality and on time from concept to commercialization.

To find out more details about UPM’s capabilities, or to arrange a visit to our Bristol Tennessee facility, please contact one of our Business Development professionals that can be found on our contact page.

  • Upcoming UPM Events

    2015 AAPS Annual Meeting and Exposition
    Orange County Convention Center,
    Orlando, FL
    Booth #1149
    October 25-29 2015

Follow Us


All works © UPM Pharmaceuticals 2016